跳至主要内容
临床试验/NCT04303468
NCT04303468已完成不适用

The Effects of a GABA Supplement Versus a Placebo on Glucose Tolerance and Blood Pressure in Prediabetics

Wageningen University1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2020年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
Postprandial glycaemic response during a 2 hour oral glucose tolerance test (OGTT)

研究概览

简要总结

In this double-blind parallel placebo controlled intervention study the effects of 3 times daily 500 mg gamma-aminobutyric acid (GABA) supplementation on glucose tolerance and cardiovascular health will be assessed in prediabetics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 50 and 70
  • BMI higher or equal to 27 kg/m2
  • Impaired fasting glucose (fasting glucose ≥ 6.1 and ≤ 6.9 mmol/L) or/and
  • Impaired glucose tolerance (glucose levels ≥ 7.8 and ≤ 11.1 mmol/L, 2-hours after an OGTT or/and glucose levels ≥8.6 mmol/L, 1-hour after an OGTT)

排除标准

  • Has been diagnosed with diabetes
  • Having other conditions, like liver, pancreatic, cardiovascular, gastro-intestinal or endocrine diseases, that could influence the study results
  • Use of medications or supplements that could influence the study results
  • Sensitive to medical skin adhesives
  • More than 5kg weight change in the past 12 weeks
  • Excessive alcohol consumption (>21 glasses/week for men and >14 glasses/week for women on average)
  • Being an employee of Wageningen University, division Human Nutrition and Health
  • Currently a research subject in other research

结局指标

主要结局

Postprandial glycaemic response during a 2 hour oral glucose tolerance test (OGTT)

时间窗: blood will be drawn at baseline and after 30, 60 and 120 minutes, before and after the 12 weeks intervention

A 2 hour oral glucose tolerance test with 75gr glucose

次要结局

  • Postprandial insulin and glucagon response during a 2 hour OGTT,(blood will be drawn at baseline and after 30, 60 and 120 minutes, before and after the 12 weeks intervention)
  • Plasma free fatty acids(before and after the 12 weeks intervention)
  • HbA1c(before and after the 12 weeks intervention)
  • Glucose variability(5 days during which they eat their habitual diet, before and after the 12 weeks intervention)
  • Blood pressure(Dynamic measurement: 24 hours, before and after the 12 weeks intervention)
  • Heart rate(before and after the 12 weeks intervention)
  • Concentrion of markers of inflammation in blood(before and after the 12 weeks intervention)
  • Concentration of triglycerides in blood(before and after the 12 weeks intervention)
  • Concentration of LDL and HDL cholesterol in blood(before and after the 12 weeks intervention)
  • Concentration of ALAT and ASAT in blood(before and after the 12 weeks intervention)
  • Acute effects of GABA on postprandial glucose(2 hours, after a single administration of 500 mg GABA)
  • Acute effects of GABA on blood pressure(for 24 hours during which GABA is taken 3 times, each time before the main meal)
  • Sleep quality(before and after the 12 weeks intervention)
  • Feelings of depression(before and after the 12 weeks intervention)
  • Feelings of anxiety(before and after the 12 weeks intervention)
  • Plasma GABA concentration(before and after the 12 weeks intervention)
  • Plasma glutamate concentration(before and after the 12 weeks intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验